Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head…
- B. Brockstein, D. Haraf, +9 authors E. Vokes
- Medicine
- Journal of clinical oncology : official journal…
- 1 February 1998
PURPOSE
We have previously demonstrated high locoregional control rates in patients with poor-prognosis head and neck cancer using fluorouracil (5-FU), hydroxyurea (HU), and concomitant radiotherapy… Expand
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.
- E. Vokes, R. Ansari, +8 authors H. Golomb
- Medicine
- Annals of oncology : official journal of the…
- 1 October 1998
BACKGROUND
9-Aminocamptothecin (9-AC) is a synthetic analogue of camptothecin. Phase I studies, identified the maximum tolerated dose as 1416 micrograms/m2/day x 3 as continuous intravenous infusion… Expand
DAS BANNWABENVERFAHREN ALS ELEMENT IMKERLICHER BETRIEBSWEISE BEI STARKEM BEFALL MIT VARROA JACOBSONI OUD
- V. Maul, A. Klepsch, U. Assmann-Werthmüller
- Biology
- 1988
Phase II trial of paclitaxel and topotecan with granulocyte colony-stimulating factor support in stage IV breast cancer.
- G. Fleming, J. Kugler, +7 authors E. Vokes
- Medicine
- Journal of clinical oncology : official journal…
- 1 June 1998
PURPOSE
This multicenter phase II trial investigated the efficacy and safety of a combination of paclitaxel and topotecan in patients with pretreated metastatic breast cancer. Plasma levels of… Expand
ESTIMATING HERITABILITIES OF WORKER CHARACTERS : A NEW APPROACH USING LAYING WORKERS OF THE CAPE HONEYBEE (APIS MELLIFERA CAPENSIS ESCH.)
- R. F. Moritz, A. Klepsch
- Biology
- 1985
Bestimmung von Transferfaktoren von Caesium in der Kette Boden—Rapspflanze—Rapsblüte—Rapshonig
- D. Molzahn, A. Klepsch, U. Assmann-Wertmüller
- Biology
- 1989
ADVISORY COMMITTEE ON NOVEL FOODS AND PROCESSES APPLICATION FOR THE APPROVAL OF LYCOPENE-RICH OLEORESIN FROM TOMATO UK OPINION
- A. Klepsch, P. B. Ottaway
- 2005
On 7 September 2004, the UK Competent Authority accepted an application from Berry Ottaway & Associates Ltd (UK) on behalf of LycoRed (Israel) for a lycopenerich oleoresin derived from tomato as a… Expand
Initial Assessment of the Application for the Approval of Calcium-L-Methylfolate under the Novel Food Regulation (EC) No
- A. Klepsch
- 2012
The novel ingredient is chemically synthesised from folic acid and glucosamine hydrochloride and is intended to be used as an alternative source of folate in food supplements in accordance with… Expand
R&D Programmes of the European communities in biotechnology and related areas
- D. Nettancourt, A. Klepsch
- Biology
- 1990
The research programme BRIDGE ‐ Biotechnology Research for Innovation, Development, and Growth in Europe ‐ the “successor of BEP (Biomolecular Engineering Programme 1982–1986) and BAP (Biotechnology… Expand